{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:14:34Z","timestamp":1768817674688,"version":"3.49.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 103-2314-B-418-003-MY2"],"award-info":[{"award-number":["MOST 103-2314-B-418-003-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-EX105-10510PC"],"award-info":[{"award-number":["NHRI-EX105-10510PC"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-EX106-10510PC"],"award-info":[{"award-number":["NHRI-EX106-10510PC"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","award":["FEMH-EX105-10510PC"],"award-info":[{"award-number":["FEMH-EX105-10510PC"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","award":["FEMH-EX106-10510PC"],"award-info":[{"award-number":["FEMH-EX106-10510PC"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177654","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T14:07:50Z","timestamp":1494857270000},"page":"e0177654","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3121-3351","authenticated-orcid":true,"given":"Hon-Yen","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiao-Ling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Kang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenq-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Sen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Kang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzong-Shinn","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Yu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Liong","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"ref1","article-title":"Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis [published online Mar 13, 2017]","author":"WC Tsai","journal-title":"JAMA Intern Med"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"e3013","DOI":"10.1097\/MD.0000000000003013","article-title":"Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis","volume":"95","author":"WC Tsai","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamainternmed.2014.1363","article-title":"Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"174","author":"HY Wu","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"9888","key":"ref4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"V Jha","year":"2013","journal-title":"Lancet"},{"key":"ref5","article-title":"Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method [published online May 4, 2016]","author":"S Fukuma","journal-title":"Clin Exp Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"f6008","DOI":"10.1136\/bmj.f6008","article-title":"Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis","volume":"347","author":"HY Wu","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jamainternmed.2013.12700","article-title":"Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia","volume":"174","author":"TW Hsu","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/ndt\/gfs590","article-title":"Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial","volume":"28","author":"K Iseki","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10157-015-1091-5","article-title":"Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study","volume":"19","author":"M Hayashi","year":"2015","journal-title":"Clin Exp Nephrol"},{"issue":"28","key":"ref10","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"G Mancia","year":"2013","journal-title":"Eur Heart J"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"PA James","year":"2014","journal-title":"JAMA"},{"key":"ref12","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"Suppl 1","key":"ref13","first-page":"S75","article-title":"Cardiovascular disease and risk management. Sec. 9. In Standards of Medical Care in Diabetes\u20142017","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1523-1755.2004.00494.x","article-title":"The role of bradykinin in the antifibrotic actions of perindoprilat on human mesangial cells","volume":"65","author":"IZ Pawluczyk","year":"2004","journal-title":"Kidney Int"},{"issue":"9638","key":"ref15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial","volume":"372","author":"JF Mann","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/CIRCULATIONAHA.110.964171","article-title":"Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies","volume":"123","author":"SW Tobe","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2217\/cer.14.10","article-title":"Comparative effectiveness of antihypertensive drugs in patients with diabetes","volume":"3","author":"HY Wu","year":"2014","journal-title":"J Comp Eff Res"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.diabres.2013.10.005","article-title":"Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease\/mortality in type 2 diabetes","volume":"102","author":"HM Campbell","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4158\/EP12272.OR","article-title":"Angiotensin-converting enzyme inhibitors reduce albuminuria more than angiotensin receptor blockers in patients with type 2 diabetes","volume":"19","author":"NA Al-Sayed","year":"2013","journal-title":"Endocr Pract"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","article-title":"Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database","volume":"175","author":"AW Hsing","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2337\/dc12-0545","article-title":"Estimation of expected life-years saved from successful prevention of end-stage renal disease in elderly patients with diabetes: a nationwide study from Taiwan","volume":"35","author":"DC Yang","year":"2012","journal-title":"Diabetes Care"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0929-6646(10)60120-9","article-title":"2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension","volume":"109","author":"CE Chiang","year":"2010","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcma.2014.11.005","article-title":"2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension","volume":"78","author":"CE Chiang","year":"2015","journal-title":"J Chin Med Assoc"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1524-6175.2007.07194.x","article-title":"Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States","volume":"9","author":"BV Patel","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jclinepi.2005.05.005","article-title":"Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation","volume":"59","author":"BL Van Wijk","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF02600143","article-title":"The effect of prescription size on acquisition of maintenance medications","volume":"8","author":"JF Steiner","year":"1993","journal-title":"J Gen Intern Med"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ki.2014.363","article-title":"A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan","volume":"87","author":"YC Chen","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamainternmed.2014.6349","article-title":"A comparison of diagnostic imaging ordering patterns between advanced practice clinicians and primary care physicians following office-based evaluation and management visits","volume":"175","author":"DR Hughes","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"RA Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ki.2014.299","article-title":"The epidemiology and prognostic factors of mortality in critically ill children with acute kidney injury in Taiwan","volume":"87","author":"JW Chang","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/STROKEAHA.109.568956","article-title":"The effect of cuts in reimbursement on stroke outcome: a nationwide population-based study during the period 1998 to 2007","volume":"41","author":"YC Tung","year":"2010","journal-title":"Stroke"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s12350-015-0209-1","article-title":"2014 ACC\/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)","volume":"22","author":"KA Hicks","year":"2015","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2215\/CJN.11331210","article-title":"Cardiovascular and noncardiovascular mortality among men and women starting dialysis","volume":"6","author":"JJ Carrero","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"PM Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"19","key":"ref35","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1056\/NEJMoa042274","article-title":"Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy","volume":"351","author":"AH Barnett","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"M Mauer","year":"2009","journal-title":"N Engl J Med"},{"issue":"9982","key":"ref37","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","author":"SC Palmer","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1751-7176.2011.00508.x","article-title":"Angiotensin-converting enzyme inhibitors","volume":"13","author":"JL Izzo Jr.","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/01.hjh.0000234124.94013.ac","article-title":"The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension","volume":"24","author":"TM Seccia","year":"2006","journal-title":"J Hypertens"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/01.HYP.0000069699.92349.8C","article-title":"Blood pressure predicts risk of developing end-stage renal disease in men and women","volume":"41","author":"M Tozawa","year":"2003","journal-title":"Hypertension"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T19:08:05Z","timestamp":1540235285000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177654"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177654","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]}}}